Institutional Ownership
Estrella Immunopharma Inc
CUSIP 297584112*W EXP 09/29/202ESLAWQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
8
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Boothbay Fund Management, LLC | 189.9K | $201.3K |
| 2 | Robertson Stephens Wealth Management, LLC | 12.0K | $12.7K |
| 3 | D. E. Shaw & Co., Inc. | 87.5K | $6.1K |
| 4 | Yakira Capital Management, Inc. | 46.3K | $3.5K |
| 5 | Whitebox Advisors LLC | 42.3K | $3.2K |
| 6 | Clear Street Group Inc. | 34.1K | $2.6K |
| 7 | Toronto Dominion Bank | 21.6K | $1.6K |
| 8 | Skyview Investment Advisors, LLC | 62.5K | $5 |